Psilocybin can change the world. At least that’s what Paul Stamets, mycologist, scientist, and one of the key thought-leaders
Clinical-stage biotech firm Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) was up nearly 50% in trading on Tuesday after
Related Articles Much like the cannabis industry, there is no standard set for what a legal psychedelics programs looks
A majority of states will legalize psychedelics by 2037, according to a new analysis published in an American Medical
For years, medical professionals have been treating their patients with a series of drugs and therapies with limited ongoing
Congressional lawmakers didn’t include marijuana provisions in a must-pass defense bill that was released on Tuesday, but a joint
While it is still unknown whether insurance will pay for psychedelics-based mental health treatment, there is some evidence that
The future of psychedelics as an industry is dependent on the research being done today. But most psychedelics clinical
Table of Contents My mom has stories galore about smoking PCP in Central Park or taking acid while horseback
Chemically synthesized psilocybin has a long history, and there has been a lot written and discussed about the differences